Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | ESR1 | P03372 | 1/20 | 0.39 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.39 |
| ▸ | NR1H2 | P55055 | 3/20 | 0.35 |
| ▸ | NR1H3 | Q13133 | 3/20 | 0.35 |
| ▸ | MGAM | O43451 | 2/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | BRD4 | O60885 | 1/20 | 0.31 |
| ▸ | BRD2 | P25440 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.30 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.30 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2971874 | 0.80 | MAPT (0.41) | MAPTESR1ESR2NR1H2NR1H3 | |
| SCHEMBL386730 | 0.79 | ESR1 (0.39) | MAPTESR1ESR2NR1H2NR1H3 | |
| SCHEMBL9217667 | 0.78 | MAPT (0.47) | MAPTESR1ESR2NR1H2NR1H3 | |
| SCHEMBL8755988 | 0.77 | ACHE (0.40) | MAPTNR1H2NR1H3LMNAACHE | |
| SCHEMBL2974830 | 0.77 | MGAM (0.40) | MAPTESR1ESR2NR1H2NR1H3 | |
| SCHEMBL9226507 | 0.76 | MAPT (0.45) | MAPTESR1ESR2NR1H2NR1H3 | |
| SCHEMBL16325251 | 0.75 | MAPT (0.38) | MAPTESR1ESR2NR1H2NR1H3 | |
| SCHEMBL2965525 | 0.75 | MGAM (0.39) | MAPTESR1ESR2NR1H2NR1H3 | |
| SCHEMBL25284860 | 0.74 | MAPT (0.44) | MAPTESR1ESR2NR1H2NR1H3 | |
| SCHEMBL6833296 | 0.74 | MAPT (0.44) | MAPTESR1ESR2NR1H2NR1H3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 137 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3848399-B1 | TRANSITION METAL COMPOUND AND METHOD FOR PRODUCING OLEFIN POLYMER | IDEMITSU KOSAN CO (JP) | 2024-07-10 | — | — | EP | disclosed |
| US-11795188-B2 | Transition metal compound and method for producing olefin polymer | IDEMITSU KOSAN CO., LTD. (JP) | 2023-10-24 | — | — | US | disclosed |
| US-20230235202-A1 | PLASTICIZER FOR RESINS | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-07-27 | — | — | US | disclosed |
| CN-109963886-B | Phosphoguanidine group IV metal olefin polymerization catalyst | 陶氏环球技术有限责任公司 | 2023-01-06 | — | — | CN | disclosed |
| CN-115260366-A | Catalyst system for forming multi-block copolymers | 陶氏环球技术有限责任公司 | 2022-11-01 | — | — | CN | disclosed |
| US-11459409-B2 | Catalyst system for multi-block copolymer formation | DOW GLOBAL TECHNOLOGIES LLC (US) | 2022-10-04 | — | — | US | disclosed |
| CN-110582518-B | Catalyst system for forming multi-block copolymers | 陶氏环球技术有限责任公司 | 2022-08-09 | — | — | CN | disclosed |
| EP-3436488-B1 | AN OLEFIN POLYMERIZATION CATALYST | DOW GLOBAL TECHNOLOGIES LLC (US) | 2022-05-18 | — | — | EP | disclosed |
| CN-108779205-B | Olefin polymerization catalyst | 陶氏环球技术有限责任公司 | 2022-01-07 | — | — | CN | disclosed |
| US-11214632-B2 | Bis-ligated phosphaguanidine group IV metal complexes and olefin polymerization catalysts produced therefrom | DOW GLOBAL TECHNOLOGIES LLC (US) | 2022-01-04 | — | — | US | disclosed |
| EP-1247814-A1 | TRANSITION METAL COMPOUNDS, POLYMERIZATION CATALYSTS FOR OLEFINS, OLEFIN POLYMERS AND PROCESS FOR THEIR PRODUCTION | IDEMITSU PETROCHEMICAL CO., LTD. (JP) | 2002-10-09 | — | — | EP | disclosed |
| EP-1231226-A1 | ROLLED POLYPROPYLENE AND INJECTION-MOLDED POLYPROPYLENE | IDEMITSU PETROCHEMICAL CO., LTD. (JP) | 2002-08-14 | — | — | EP | disclosed |
| EP-1227112-A1 | PROPYLENE POLYMERS AND RESIN COMPOSITION AND MOLDING CONTAINING THE POLYMERS | IDEMITSU PETROCHEMICAL CO., LTD. (JP) | 2002-07-31 | — | — | EP | disclosed |
| US-20020012872-A1 | Radiation-sensitive resin composition | JSR CORPORATION (JP) | 2002-01-31 | — | — | US | disclosed |
| EP-1164433-A1 | Radiation-sensitive resin composition | JSR Corporation (JP) | 2001-12-19 | — | — | EP | disclosed |
| US-5889012-A | INSECTICIDE, ACARICIDES, FUNGICIDES | HOECHST-SCHERING AGREVO GMBH (DE) | 1999-03-30 | — | — | US | disclosed |
| EP-0714393-B1 | THIAZOLES AS ANTIVIRAL | PFIZER (US) | 1998-09-23 | — | — | EP | disclosed |
| US-5789408-A | Antiviral thiazoles | PFIZER INC. (US) | 1998-08-04 | — | — | US | disclosed |
| EP-0714393-A1 | THIAZOLES AS ANTIVIRAL | PFIZER INC. (US) | 1996-06-05 | — | — | EP | disclosed |
| WO-1995005378-A1 | ANTIVIRAL THIAZOLES | PFIZER INC. (US) | 1995-02-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11214632-B2 | Bis-ligated phosphaguanidine group IV metal complexes and olefin polymerization catalysts produced therefrom | BPGM, POLM, PARG | MAPT 2774/4885ESR1 2993/4885ESR2 4167/4885 |
| US-11795188-B2 | Transition metal compound and method for producing olefin polymer | H1-0, C9, C5 | MAPT 4097/4885ESR1 105/4885ESR2 285/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.